Transdermalt terapeutisk system for administrering av physostigmin gjennom huden og en fremgangsmåte for fremstilling av systemet

PCT No. PCT/EP93/02970 Sec. 371 Date Jul. 12, 1995 Sec. 102(e) Date Jul. 12, 1995 PCT Filed Oct. 27, 1993 PCT Pub. No. WO94/10999 PCT Pub. Date May 26, 1994A transdermal therapeutic system for the administration of physostigmine to the skin, consisting of a backing layer impermeable to active substa...

Full description

Saved in:
Bibliographic Details
Main Authors PROFITLICH, THOMAS, STANISLAUS, FRITZ, WALTER, KERSTEN, HILLE, THOMAS, DEURER, LOTHAR
Format Patent
LanguageNorwegian
Published 11.05.1995
Edition6
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:PCT No. PCT/EP93/02970 Sec. 371 Date Jul. 12, 1995 Sec. 102(e) Date Jul. 12, 1995 PCT Filed Oct. 27, 1993 PCT Pub. No. WO94/10999 PCT Pub. Date May 26, 1994A transdermal therapeutic system for the administration of physostigmine to the skin, consisting of a backing layer impermeable to active substance, a pressure-sensitive reservoir layer containing 40 to 90%-wt. polymeric material and 0.1 to 20%-wt. physostigmine base or one of the pharmaceutically acceptable salts thereof, and of a detachable protective layer covering the reservoir layer, comprises in its reservoir layer acrylate- and/or methacrylate-based polymeric material and 0.1 to 40%-wt. of a softener containing the hydroxyl group with an HLB value between 1.1 and 12.0.
Bibliography:Application Number: NO19950001864